Patents by Inventor Shifeng Pan

Shifeng Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190254217
    Abstract: A new Helianthus plant named ‘SUR67-1’ particularly distinguished by the medium to large size yellow decorative inflorescences, vigorous size plant, round mound plant habit, with a natural flowering response of early May until late September.
    Type: Application
    Filed: February 12, 2019
    Publication date: August 15, 2019
    Applicant: SYNGENTA PARTICIPATIONS AG
    Inventor: Shifeng Pan
  • Patent number: 10280139
    Abstract: Disclosed herein are novel compounds of formula (I) as described herein: and the use of such peptides in making immunoconjugates (i.e Antibody Drug Conjugates) Also described herein are immunoconjugates (i.e Antibody Drug Conjugates) comprising such novel compound linked to an antigen binding moiety, such as an antibody; where such immunoconjugates are useful for treating cell proliferative disorders. The invention further provides pharmaceutical compositions comprising these immunoconjugates, compositions comprising the immunoconjugates with a therapeutic co-agent, and methods to use these immunoconjugates and compositions for treating cell proliferation disorders.
    Type: Grant
    Filed: November 27, 2017
    Date of Patent: May 7, 2019
    Assignee: Novartis AG
    Inventors: Bernhard Hubert Geierstanger, Jan Grunewald, Weijia Ou, Shifeng Pan, Tetsuo Uno, Yongqin Wan, Xing Wang
  • Patent number: 10251893
    Abstract: The present invention relates to methods for modulating the Wnt signaling pathway using compounds of Formula (1), wherein A1, Y and Z all represent rings.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: April 9, 2019
    Assignee: Novartis AG
    Inventors: Dai Cheng, Wenqi Gao, Dong Han, Shifeng Pan, Guobao Zhang
  • Publication number: 20180213741
    Abstract: The present invention provides an interspecific Helianthus plant comprising a genetic determinant responsible for an indeterminate phenotype. Methods of making said plant are also provided.
    Type: Application
    Filed: July 22, 2016
    Publication date: August 2, 2018
    Applicant: SYNGENTA PARTICIPATIONS AG
    Inventors: Shifeng Pan, Jason Jandrew
  • Publication number: 20180155281
    Abstract: Disclosed herein are novel compounds of formula (I) as described herein: and the use of such peptides in making immunoconjugates (i.e Antibody Drug Conjugates) Also described herein are immunoconjugates (i.e Antibody Drug Conjugates) comprising such novel compound linked to an antigen binding moiety, such as an antibody; where such immunoconjugates are useful for treating cell proliferative disorders. The invention further provides pharmaceutical compositions comprising these immunoconjugates, compositions comprising the immunoconjugates with a therapeutic co-agent, and methods to use these immunoconjugates and compositions for treating cell proliferation disorders.
    Type: Application
    Filed: November 27, 2017
    Publication date: June 7, 2018
    Inventors: Bernhard Hubert Geierstanger, Jan Grunewald, Weijia OU, Shifeng Pan, Tetsuo Uno, Yongqin Wan, Xing Wang
  • Patent number: 9884817
    Abstract: Disclosed herein are novel compounds of formula (I) as described herein: and the use of such peptides in making immunoconjugates (i.e Antibody Drug Conjugates) Also described herein are immunoconjugates (i.e Antibody Drug Conjugates) comprising such novel compound linked to an antigen binding moiety, such as an antibody; where such immunoconjugates are useful for treating cell proliferative disorders. The invention further provides pharmaceutical compositions comprising these immunoconjugates, compositions comprising the immunoconjugates with a therapeutic co-agent, and methods to use these immunoconjugates and compositions for treating cell proliferation disorders.
    Type: Grant
    Filed: June 11, 2015
    Date of Patent: February 6, 2018
    Assignee: Novartis AG
    Inventors: Bernhard Hubert Geierstanger, Jan Grunewald, Weijia Ou, Shifeng Pan, Tetsuo Uno, Yongqin Wan, Xing Wang
  • Publication number: 20180000832
    Abstract: The present invention relates to methods for modulating the Wnt signaling pathway using compounds of Formula (1), wherein A1, Y and Z all represent rings.
    Type: Application
    Filed: September 8, 2017
    Publication date: January 4, 2018
    Inventors: Dai CHENG, Wenqi GAO, Dong HAN, Shifeng PAN, Guobao ZHANG
  • Publication number: 20170339809
    Abstract: A new Lantana plant named ‘LANZ0013’ particularly distinguished by the large sized tri-colored, golden, orange and scarlet red flowers, excellent floriferousness, and dense mounding habit with medium green foliage.
    Type: Application
    Filed: June 21, 2016
    Publication date: November 23, 2017
    Applicant: SYNGENTA PARTICIPATIONS AG
    Inventor: Shifeng Pan
  • Publication number: 20170239296
    Abstract: The present invention relates to compounds and compositions for expanding the number of CD34+ cells for transplantation. The invention further relates to a cell population comprising expanded hematopoietic stem cells (HSCs) and its use in autologous or allogeneic transplantation for the treatment of patients with inherited immunodeficient and autoimmune diseases and diverse hematopoietic disorders to reconstitute the hematopoietic cell lineages and immune system defense.
    Type: Application
    Filed: January 18, 2017
    Publication date: August 24, 2017
    Inventors: Anthony E. Boitano, Michael Cooke, Shifeng Pan, Peter G. Schultz, John Tellew, Yongqin Wan, Xing Wang
  • Publication number: 20170121282
    Abstract: Disclosed herein are novel compounds of formula (I) as described herein: and the use of such peptides in making immunoconjugates (i.e Antibody Drug Conjugates) Also described herein are immunoconjugates (i.e Antibody Drug Conjugates) comprising such novel compound linked to an antigen binding moiety, such as an antibody; where such immunoconjugates are useful for treating cell proliferative disorders. The invention further provides pharmaceutical compositions comprising these immunoconjugates, compositions comprising the immunoconjugates with a therapeutic co-agent, and methods to use these immunoconjugates and compositions for treating cell proliferation disorders.
    Type: Application
    Filed: June 11, 2015
    Publication date: May 4, 2017
    Applicant: NOVARTIS AG
    Inventors: Bernhard Hubert Geierstanger, Jan Grunewald, Weijia OU, Shifeng Pan, Tetsuo Uno, Yongqin Wan, Xing Wang
  • Patent number: 9580426
    Abstract: The present invention relates to compounds and compositions for expanding the number of CD34+ cells for transplantation. The invention further relates to a cell population comprising expanded hematopoietic stem cells (HSCs) and its use in autologous or allogeneic transplantation for the treatment of patients with inherited immunodeficient and autoimmune diseases and diverse hematopoietic disorders to reconstitute the hematopoietic cell lineages and immune system defense.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: February 28, 2017
    Assignees: Novartis AG, The Scripps Research Institute
    Inventors: Anthony E. Boitano, Michael Cooke, Shifeng Pan, Peter G. Schultz, John Tellew, Yongqin Wan, Xing Wang
  • Patent number: PP28174
    Abstract: A new Lantana plant named ‘LANZ0007’ particularly distinguished large sized golden yellow to orange flowers with an orange throat, dark green foliage, dense mounding habit, early flowering, excellent floriferousness, and good heat tolerance compared with control.
    Type: Grant
    Filed: May 19, 2015
    Date of Patent: July 11, 2017
    Assignee: Syngenta Participations AG
    Inventor: Shifeng Pan
  • Patent number: PP28175
    Abstract: A new Lantana plant named ‘LANZ0008’ particularly distinguished large sized, cream yellow to pink flowers with an yellow throat, dark green foliage, early flowering and excellent floriferousness, spreading plant habit and good heat tolerance compared to control.
    Type: Grant
    Filed: May 20, 2015
    Date of Patent: July 11, 2017
    Assignee: Syngenta Participations AG
    Inventor: Shifeng Pan
  • Patent number: PP29373
    Abstract: A new Lantana plant named ‘LANZ0013’ particularly distinguished by the large sized tri-colored, golden, orange and scarlet red flowers, excellent floriferousness, and dense mounding habit with medium green foliage.
    Type: Grant
    Filed: June 21, 2016
    Date of Patent: June 12, 2018
    Assignee: Syngenta Participations AG
    Inventor: Shifeng Pan
  • Patent number: PP29653
    Abstract: A new Lantana plant named ‘LANZ0015’ having large sized tri-color, yellow, orange and red flowers, excellent floriferousness, and uniform dense spreading habit with medium green foliage.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: September 11, 2018
    Assignee: Syngenta Participations AG
    Inventor: Shifeng Pan
  • Patent number: PP29654
    Abstract: A new Lantana plant named ‘LANZ0014’ particularly distinguished by the large sized bi-color, yellow and white flowers, excellent floriferousness, and uniform dense spreading habit with medium green foliage.
    Type: Grant
    Filed: October 17, 2016
    Date of Patent: September 11, 2018
    Assignee: Syngenta Participations AG
    Inventor: Shifeng Pan
  • Patent number: PP29655
    Abstract: A new Lantana plant named ‘LANZ0012’ particularly distinguished by uniform golden yellow flowers, large inflorescences, green foliage, and vigorous trailing but tight branching plant habit.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: September 11, 2018
    Assignee: Syngenta Participations AG
    Inventor: Shifeng Pan
  • Patent number: PP30188
    Abstract: A new cultivar of Calendula plant named ‘CDAZ0001’ particularly distinguished by orange color with a gold center flower color, single flower form, and mound spreading plant habit.
    Type: Grant
    Filed: July 7, 2017
    Date of Patent: February 12, 2019
    Assignee: Syngenta Participations AG
    Inventor: Shifeng Pan
  • Patent number: PP30189
    Abstract: A new cultivar of Caledula plant named ‘CDAZ0002’ particularly distinguished by apricot orange flower color and double flower form.
    Type: Grant
    Filed: July 7, 2017
    Date of Patent: February 12, 2019
    Assignee: Syngenta Participations AG
    Inventor: Shifeng Pan
  • Patent number: PP30518
    Abstract: A new cultivar of Calendula plant named ‘CDAZ0003’ particularly distinguished by bright yellow flower color, semi-double flower form, and mound spreading plant habit.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: May 21, 2019
    Assignee: Syngenta Participations AG
    Inventor: Shifeng Pan